berberine and sch 23390

berberine has been researched along with sch 23390 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jin, GZ; Mo, J; Sun, PH; Yu, LP; Zhang, H; Zhen, X	1
Kaneko, A; Kawano, M; Matsushita, S; Takagi, R	1

Other Studies

2 other study(ies) available for berberine and sch 23390

Article	Year
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiology of aging, 2010, Volume: 31, Issue:6 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Antipsychotic Agents; Benzazepines; Berberine; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Interactions; Dyskinesias; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Serotonin Receptor Agonists; Transfection; Tritium	2010
Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses. Journal of neuroimmunology, 2015, Dec-15, Volume: 289 Topics: Adaptive Immunity; Animals; Benzazepines; Berberine; Bone Marrow; Colitis; Cytokines; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Dopamine Antagonists; Immunity, Innate; Lipopolysaccharides; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Pyrroles; Receptors, Dopamine; Receptors, Serotonin; Time Factors	2015

Article

Year

L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

Neurobiology of aging, 2010, Volume: 31, Issue:6

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Antipsychotic Agents; Benzazepines; Berberine; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Interactions; Dyskinesias; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Serotonin Receptor Agonists; Transfection; Tritium

2010

Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses.

Journal of neuroimmunology, 2015, Dec-15, Volume: 289

Topics: Adaptive Immunity; Animals; Benzazepines; Berberine; Bone Marrow; Colitis; Cytokines; Dendritic Cells; Dextran Sulfate; Disease Models, Animal; Dopamine Antagonists; Immunity, Innate; Lipopolysaccharides; Lymph Nodes; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Protein Binding; Pyridines; Pyrroles; Receptors, Dopamine; Receptors, Serotonin; Time Factors

2015